Computing Resources: Difference between revisions
Jump to navigation
Jump to search
(right align) |
(more right align) |
||
| Line 12: | Line 12: | ||
| Methylome || Precision Medicine || Epigenomics || | | Methylome || Precision Medicine || Epigenomics || | ||
|- | |- | ||
| Mass spectra || DESI || Leukemia Biology / Pathology || style="text-align:right;" |4 || - || - || - || - | | Mass spectra || DESI || Leukemia Biology / Pathology || style="text-align:right;" |4 || style="text-align:right;" |- || style="text-align:right;" |- || style="text-align:right;" |- || style="text-align:right;" |- | ||
|- | |- | ||
| Imaging || Drug Screening || Leukemia Biology || || || 15 || 25 || | | Imaging || Drug Screening || Leukemia Biology || || || style="text-align:right;" |15 || style="text-align:right;" |25 || | ||
|- | |- | ||
| Panel || Drug Screening || Leukemia Biology || || || || 0.4 || | | Panel || Drug Screening || Leukemia Biology || || || || style="text-align:right;" |0.4 || | ||
|- | |- | ||
| Methylome || Drug Screening || Leukemia Biology || || || || 0.03 || | | Methylome || Drug Screening || Leukemia Biology || || || || style="text-align:right;" |0.03 || | ||
|- | |- | ||
| RNASeq || Drug Screening || Leukemia Biology || || || || 0.4 || | | RNASeq || Drug Screening || Leukemia Biology || || || || style="text-align:right;" |0.4 || | ||
|- | |- | ||
|} | |} | ||
Revision as of 17:25, 15 April 2024
| Type of Data | Project | Lab | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| MRD | Routine | Molecular Biology | |||||
| Exome | Precision Medicine | Epigenomics | |||||
| ctDNA | Circular Tumoral DNA | Molecular Biology | |||||
| Methylome | Precision Medicine | Epigenomics | |||||
| Mass spectra | DESI | Leukemia Biology / Pathology | 4 | - | - | - | - |
| Imaging | Drug Screening | Leukemia Biology | 15 | 25 | |||
| Panel | Drug Screening | Leukemia Biology | 0.4 | ||||
| Methylome | Drug Screening | Leukemia Biology | 0.03 | ||||
| RNASeq | Drug Screening | Leukemia Biology | 0.4 |